Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Controlled Study ◽

Randomized Controlled ◽

Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study

Digestive and Liver Disease ◽

10.1016/j.dld.2012.01.017 ◽

2012 ◽

Vol 44 (7) ◽

pp. 603-609 ◽

Cited By ~ 11

Author(s):

Luca S. Belli ◽

Riccardo Volpes ◽

Ivo Graziadei ◽

Stefano Fagiuoli ◽

Peter Starkel ◽

...

Keyword(s):

Liver Transplantation ◽

Hepatitis C ◽

Antiviral Therapy ◽

Controlled Study ◽

Fibrosis Progression ◽

Randomized Controlled ◽

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(08)79093-7 ◽

2008 ◽

Vol 2008 ◽

pp. 267-269

Author(s):

G.A. Makar

Keyword(s):

Liver Transplantation ◽

Hepatitis C ◽

Antiviral Therapy ◽

Controlled Study ◽

Randomized Controlled ◽

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(07)61685-7 ◽

2007 ◽

Vol 46 ◽

pp. S39-S40 ◽

Cited By ~ 3

Author(s):

J.A. Carrion ◽

M. Navasa ◽

M. Garcia-Retortillo ◽

J.C. Garcia-Pagan ◽

G. Crespo ◽

...

Keyword(s):

Liver Transplantation ◽

Hepatitis C ◽

Antiviral Therapy ◽

Disease Progression ◽

Controlled Study ◽

Randomized Controlled ◽

195 CYCLOSPORINE HELPS TO ACHIEVE A HIGHER SVR IN PATIENTS RECEIVING PEG-INTERFERON/RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: FINAL ANALYSIS OF A RANDOMIZED-CONTROLLED STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(08)60197-x ◽

2008 ◽

Vol 48 ◽

pp. S82

Author(s):

R.J. Firpi ◽

C. Soldevila-Pico ◽

G. Morelli ◽

R. Cabrera ◽

C. Levy ◽

...

Keyword(s):

Liver Transplantation ◽

Hepatitis C ◽

Final Analysis ◽

Controlled Study ◽

Recurrent Hepatitis ◽

Randomized Controlled ◽

Recurrent Hepatitis C

Response of Hepatitis C Genotype-4 Naive Patients to 24 Weeks of Peg-Interferon-alpha2b/Ribavirin or Induction-Dose Interferon-alpha2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2005.00253.x ◽

2005 ◽

Vol 100 (11) ◽

pp. 2447-2452 ◽

Cited By ~ 51

Author(s):

Abdel-Rahman El-Zayadi ◽

Mohy Attia ◽

Eman M. F. Barakat ◽

Hanaa M. Badran ◽

Hassan Hamdy ◽

...

Keyword(s):

Hepatitis C ◽

Controlled Study ◽

Genotype 4 ◽

Induction Dose ◽

Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study

Hepatology Research ◽

10.1111/hepr.12938 ◽

2017 ◽

Vol 48 (3) ◽

pp. E146-E154 ◽

Cited By ~ 1

Author(s):

Goki Suda ◽

Jun Ito ◽

Atsushi Nagasaka ◽

Yoshiya Yamamoto ◽

Ken Furuya ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Combination Therapy ◽

Pegylated Interferon ◽

Controlled Study ◽

Hepatitis C Virus Infection ◽

Genotype 1 ◽

Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study

American Journal of Transplantation ◽

10.1111/ajt.12083 ◽

2013 ◽

Vol 13 (4) ◽

pp. 1047-1054 ◽

Cited By ~ 67

Author(s):

R. T. Chung ◽

F. D. Gordon ◽

M. P. Curry ◽

T. D. Schiano ◽

S. Emre ◽

...

Keyword(s):

Monoclonal Antibody ◽

Liver Transplantation ◽

Human Monoclonal Antibody ◽

Controlled Study ◽

Viral Rebound ◽

Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study

Journal of Viral Hepatitis ◽

10.1046/j.1365-2893.2003.00426.x ◽

2003 ◽

Vol 10 (3) ◽

pp. 215-223 ◽

Cited By ~ 3

Author(s):

I. Portal ◽

M. Bourliere ◽

P. Halfon ◽

V. De Ledinghen ◽

P. Couzigou ◽

...

Keyword(s):

Hepatitis C ◽

Controlled Study ◽

Sustained Virological Response in Chronic Hepatitis C Patients after a 6- and a 36-Month Interferon-a2b Treatment Schedule. A Multicenter, Randomized, Controlled Study

Scandinavian Journal of Gastroenterology ◽

10.1080/00365520119318 ◽

2001 ◽

Vol 36 (1) ◽

pp. 97-104

Author(s):

M. Damen, C. J. Weegink, E. P. Maus

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Controlled Study ◽

Treatment Schedule ◽

Randomized Controlled ◽

Chronic Hepatitis C Patients

106 International, multicenter, randomized, controlled study for the treatment of patients with chronic hepatitis C and persistently normal ALT levels with peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (copegus®)

Hepatology ◽

10.1016/s0270-9139(03)80149-0 ◽

2003 ◽

Vol 38 ◽

pp. 208-208 ◽

Cited By ~ 12

Author(s):

S ZEUZEM ◽

M DIAGO ◽

E GANE ◽

R REDDY ◽

P POCKROS ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Randomized Controlled ◽

Normal Alt ◽

Peginterferon Alfa ◽

International Multicenter